Factors associated with early cancer-related death after curative hepatectomy for solitary small hepatocellular carcinoma without macroscopic vascular invasion

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 21, Issue 2, 2014, Pages 142-147

  Sasaki, Kazunari ^a   Matsuda, Masamichi ^a   Ohkura, Yu ^a   Kawamura, Yusuke ^a   Inoue, Masafumi ^a   Hashimoto, Masaji ^a   Ikeda, Kenji ^a   Kumada, Hiromitsu ^a   Watanabe, Goro ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Early cancer related death; Hepatectomy; Hepatocellular carcinoma

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CONTROLLED STUDY; EARLY CANCER; EARLY CANCER RELATED DEATH; FEMALE; HEPATOCELLULAR CARCINOMA WITHOUT MACROSCOPIC VASCULAR INVASION; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; PREDICTOR VARIABLE; PREOPERATIVE PERIOD; PRIMARY MEDICAL CARE; RISK FACTOR; TUMOR DIFFERENTIATION; TUMOR VOLUME; YOUNG ADULT; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; FORECASTING; LIVER NEOPLASMS; MORTALITY; PATHOLOGY; TUMOR RECURRENCE;

ADULT; AGED; BLOOD LOSS, SURGICAL; CARCINOMA, HEPATOCELLULAR; FEMALE; FORECASTING; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS;

EID: 84897042119     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.13     Document Type: Article

References (25)

1. Poon RT, Fan ST, Ng IO, Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg. 2000;231:544-51.
2. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200-7.
3. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res. 2007;37:676-91.
4. Wakai T, Shirai Y, Sakata J, Kaneko K, Cruz PV, Akazawa K, et al. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol. 2007;14:1356-65.
5. Fan ST, Poon RT, Yeung C, Lam CM, Lo CM, Yuen WK, et al. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg. 2011;98:1292-300.
6. Tremosini S, Reig M, de Lope CR, Forner A, Bruix J. Treatment of early hepatocellular carcinoma: Towards personalized therapy. Dig Liver Dis. 2010;42(Suppl 3):S242-8.
7. Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg. 2007;245:909-22.
8. Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011;29:339-64.
9. Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: An update. Hepatology. 2011;53:1020-2.
10. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASLEORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 2012;56:908-43.
11. The general rules for the clinical and pathological study of primary liver cancer by Liver Cancer Study Group of Japan, 3rd English edn. Tokyo: Kanehara; 2010.
12. Hashimoto M, Sasaki K, Moriyama J, Matsuda M, Watanabe G. Resection of peritoneal metastases in patients with hepatocellular carcinoma. Surgery. 2013;153:727-31.
13. Hosaka T, Ikeda K, Kobayashi M, Hirakawa M, Kawamura Y, Yatsuji H, et al. Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinoma. Liver Int. 2009;29:736-42.
14. Moriguchi M, Takayama T, Higaki T, Kimura Y, Yamazaki S, Nakayama H, et al. Early cancer-related death after resection of hepatocellular carcinoma. Surgery. 2012;151:232-7.
15. Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Tahara M, Kakisaka T, et al. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma. World J Surg Oncol. 2012;10:107.
16. Hayashi M, Shimizu T, Hirokawa F, Inoue Y, Komeda K, Asakuma M, et al. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma. Am Surg. 2011;77:572-8.
17. Yamanaka J, Yamanaka N, Nakasho K, Tanaka T, Ando T, Yasui C, et al. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. J Gastroenterol Hepatol. 2000;15:1192-8.
18. Chun JM, Kwon HJ, Sohn J, Kim SG, Park JY, Bae HI, et al. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. J Surg Oncol. 2011;103:148-51.
19. Kondo K, Chijiiwa K, Makino I, Kai M, Maehara N, Ohuchida J, et al. Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2005;12:399-404.
20. Kenmochi K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC. Liver. 1987;7:18-26.
21. Nam SW, Park JY, Ramasamy A, Shevade S, Islam A, Long PM, et al. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology. 2005; 42:809-18.
22. Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M, et al. Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone. J Gastroenterol Hepatol. 2001;16:1290-6.
23. Endo K, Ueda T, Ueyama J, Ohta T, Terada T. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol. 2000;31:558-65.
24. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009;249:617-23.
25. Samuel M, Chow PK, Chan Shih-Yen E, Machin D, Soo KC. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev. 2009; (1):CD001199.